3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow pegylated interferon: new trials by email Literature Review of pegylated interferon trials Research Report on pegylated interferon
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients midazolam, BI 201335, tenofovir - Hepatitis C, Chronic | Phase 1 | Completed | Boehringer Ingelheim | 72 | 2012-04-01 | 2016-06-10 |
| Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment Tipranavir, Ritonavir, Pegylated interferon - Hepatic Insufficiency | Phase 1 | Completed | Boehringer Ingelheim | 36 | 2006-01-01 | 2025-01-22 |
| Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C valopicitabine, pegylated interferon - Chronic Hepatitis C | Phase 1 / Phase 2 | Completed | Merck Sharp & Dohme LLC | 2004-07-01 | 2010-06-10 |
Hepatitis C, Chronic (2) · Hepatic Insufficiency (1)
Boehringer Ingelheim (2) · Merck Sharp & Dohme LLC (1)
United States (2) · Canada (1) · Germany (1) · Puerto Rico (1)